The drop concludes that the results were not good as the market expected.
If you look closely, other than immediate effect on the bacteria, it did not have prolonged eradication effect like Mupirocin and therefore it was not as good as the available antibiotic.
However, it does have potential as we all believe but the road ahead is not going to be smooth with so many unknowns.
Next trigger for a SP increase could be announcement of company's plans on further studies on BTX 1801.
Until then SP could drift lower.
Bot Chart, page-4537
-
- There are more pages in this discussion • 9,293 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |